11.12.2012 17:40
Bewerten
 (0)

In France, GE Healthcare Announces the First Global Installation of Its Discovery IGS 730 System for Hybrid Operating Rooms

GE Healthcare announces the first global installation in France of the Discovery IGS 730 system for hybrid Operating Rooms and imaging departments. It will allow performing complex minimally-invasive endovascular and percutaneous procedures on inoperable patients suffering from cardiovascular pathologies such as ruptured aorta aneurysms, fainting spells or cerebrovascular accidents. "The Discovery IGS 730 is a true innovation allowing us to conduct complex minimally invasive hybrid procedures in a secure setting. With this technology we are treating "high risk” patients unfit for open surgery. In a year, this technology will allow us to perform 500 complex aortic repairs in such patients. The majority of patients will have a reduced hospital stay and a quick return to normal activity. In addition, in terms of mobility/patient access and the ergonomics of the operating room, this is a huge step forward”, said Prof. Haulon, Head of Vascular Surgery Department, University Hospital of Lille, France.

World's first installation and clinical use of GE Healthcare’s Discovery IGS 730 at the Lille Univer ...

World's first installation and clinical use of GE Healthcare’s Discovery IGS 730 at the Lille University Hospital in France.

A major innovation developed and produced in France: Discovery IGS 730

The hybrid operating room allows both open surgery and catheter-based imaging therapies to take place in the same operating room. The hybrid OR enables multiple physicians (surgeons, Interventionalist, nurses, anaesthesiologists, and technicians) to perform a new spectrum of minimally invasive therapies with the goal of ultimately enabling better patient care. These complex minimally-invasive endovascular and percutaneous procedures will allow discharging patients much faster (5 days in comparison to an average of 10 days) and reduce patient rehabilitation.

"In designing the Discovery IGS 730, it was always our goal to provide the latest in interventional efficiency – with high precision imaging capability and exceptional in-room mobility. This solution aims to accommodate a wide range of minimally invasive and surgical procedures. Due to the technological innovation and the advanced application portfolio available, we hope it will allow our customers to explore and discover new ways within both the Interventional and the Operating Room.” says Chantal Le Chat, General Manager, Premium Angiography, GE Healthcare, Detection & Guidance Solutions.

The Discovery IGS 730 is a laser-guided, mobile gantry, a first-of-its kind in interventional imaging. The system is neither floor nor ceiling mounted and enables full patient access, creating an interventional environment without boundaries. It has the mobility of a C-arm with the power and image quality of a fixed system, allowing multiple parking possibilities, while helping maintain sterility for a flexible and secure OR environment. It is intended for oncology (hepatic and bone tumors), neurology (aneurysms and brain tumors) as well as cardiovascular patients (stent appositions). Discovery IGS 730 is the only x-ray angiographic medical imaging system with such mobility in the world.

Discovery IGS 730, the outcome of a 32 million Euros investment in France

In total, 12 international patents have been registered for this ground-breaking technological innovation. Discovery IGS 730 has been developed within the IRIMI project, a public-private partnership that involved several French laboratories and partially funded by the French government (IRIMI project).

"With the installation of the Discovery IGS 730 in France, our R&D factory of Buc (Parisian Region) has become the birthplace of a ground-breaking innovation in worldwide surgery. With this, our 420 France-based researchers have proven to be able to find technological innovations that allow new treatments, reduce risks for the patients and provide solutions for health professionals” declared Robert Sigal, CEO, GE Healthcare France.

About GE Healthcare

GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems. Our "healthymagination” vision for the future invites the world to join us on our journey as we continuously develop innovations focused on increasing access and improving quality and affordability around the world. Headquartered in the United Kingdom, GE Healthcare is a unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employees are committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at www.gehealthcare.com. For our latest news, please visit http://newsroom.gehealthcare.com.

Nachrichten zu General Electric Co.

  • Relevant
  • Alle
  • vom Unternehmen
  • Peer Group
  • ?

Um Ihnen die Übersicht über die große Anzahl an Nachrichten, die jeden Tag für ein Unternehmen erscheinen, etwas zu erleichtern, haben wir den Nachrichtenfeed in folgende Kategorien aufgeteilt:

Relevant: Nachrichten von ausgesuchten Quellen, die sich im Speziellen mit diesem Unternehmen befassen

Alle: Alle Nachrichten, die dieses Unternehmen betreffen. Z.B. auch Marktberichte die außerdem auch andere Unternehmen betreffen

vom Unternehmen: Nachrichten und Adhoc-Meldungen, die vom Unternehmen selbst veröffentlicht werden

Peer Group: Nachrichten von Unternehmen, die zur Peer Group gehören

Analysen zu General Electric Co.

  • Alle
  • Buy
  • Hold
  • Sell
  • ?
28.03.2017General Electric UnderweightJP Morgan Chase & Co.
24.02.2017General Electric (GE) kaufenBernstein Research
24.01.2017General Electric (GE) buyUBS AG
17.01.2017General Electric (GE) buyStifel, Nicolaus & Co., Inc.
13.01.2017General Electric (GE) verkaufenJP Morgan Chase & Co.
24.02.2017General Electric (GE) kaufenBernstein Research
24.01.2017General Electric (GE) buyUBS AG
17.01.2017General Electric (GE) buyStifel, Nicolaus & Co., Inc.
06.01.2017General Electric (GE) buyUBS AG
16.12.2016General Electric (GE) OutperformBernstein Research
12.12.2016General Electric (GE) NeutralGoldman Sachs Group Inc.
27.11.2016General Electric (GE) NeutralGoldman Sachs Group Inc.
24.10.2016General Electric (GE) market-performBernstein Research
24.10.2016General Electric (GE) NeutralGoldman Sachs Group Inc.
06.10.2016General Electric (GE) Equal-WeightMorgan Stanley
28.03.2017General Electric UnderweightJP Morgan Chase & Co.
13.01.2017General Electric (GE) verkaufenJP Morgan Chase & Co.
23.09.2016General Electric (GE) UnderweightJP Morgan Chase & Co.
25.07.2016General Electric (GE) UnderweightJP Morgan Chase & Co.
27.05.2016General Electric (GE) UnderweightJP Morgan Chase & Co.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für General Electric Co. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"

Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"

Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen
Anzeige
Anzeige
Börse Stuttgart Anlegerclub

Familienunternehmen: Rendite und Sicherheit!

Zwischen Eigentümern und Managern eines Unternehmens besteht häufig ein Interessenskonflikt hinsichtlich kurz- und langfristiger Ziele. Familien- und eigentümergeführte Unternehmen haben solche Konflikte meist nicht. Für Aktionäre sind solche Unternehmen daher meist eine lohnenswerte Investitionsmöglichkeit. Im neuen Anlegermagazin lesen Sie, welche drei Familienunternehmen einen näheren Blick wert sind.
Anlegermagazin kostenlos erhalten

Heute im Fokus

DAX schließt deutlich fester -- Dow Jones am Ende fester -- Commerzbank will wohl Wertpapierabwicklung auslagern -- Short-Angriff: AURELIUS-Aktien brechen massiv ein -- EVOTEC, E.ON, Snapchat im Fokus

S&P erhöht Ratings von Commerzbank und Deutsche Bank. VW-Aufsichtsrat schlägt Entlastung aller Vorstandsmitglieder vor. Bankaktien europaweit gefragt - Umfeld hellt sich auf. Tencent steigt mit fünf Prozent bei Tesla ein. RWE signalisiert Investoren höhere Ausschüttungen ab 2019. Elon Musk gründet abermals ein neues Unternehmen.

Top-Rankings

Hier macht Arbeiten Spaß
Die besten Arbeitgeber weltweit
KW 12: Analysten-Flops der Woche
Diese Aktien stehen auf den Verkauflisten der Experten
KW 12: Analysten-Tops der Woche
Diese Aktien stehen auf den Kauflisten der Experten

Umfrage

Der bayerische Handelsverband rechnet mit einem deutlichen Anstieg der Lebensmittelverkäufe über das Internet. Wäre das auch was für Sie?

Online Brokerage über finanzen.net

Das Beste aus zwei Welten: Handeln Sie für nur 5 Euro Orderprovision* pro Trade unmittelbar aus der Informationswelt von finanzen.net!
Beliebte Suchen
DAX 30
Öl
Euro US-Dollar
Goldpreis
Meistgesucht
Daimler AG710000
Deutsche Bank AG514000
AURELIUS Equity Opp. SE & Co. KGaAA0JK2A
CommerzbankCBK100
Volkswagen AG Vz. (VW AG)766403
EVOTEC AG566480
BayerBAY001
E.ON SEENAG99
Nordex AGA0D655
Apple Inc.865985
Allianz840400
Infineon Technologies AG623100
Deutsche Telekom AG555750
BASFBASF11
SAP SE716460